Pacira | PCRX - SCHULD





SCHULD Veränderung Datum
Astellas Pharma JPY 565.95B 265.47B 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 54.99B 7.05B 2026-03
Ligand Pharmaceuticals USD 451.98M 486K 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Pfizer USD 63.19B 536M 2026-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Teva Pharmaceutical Industries USD 16.91B 187M 2026-03
Xeris Pharmaceuticals USD 258.55M 899K 2026-03
Zoetis USD 9.24B 0 2026-03